Literature DB >> 8533839

Transient leukemia with trisomy 21: description of a case and review of the literature.

S Bhatt1, R Schreck, J M Graham, J R Korenberg, C G Hurvitz, N Fischel-Ghodsian.   

Abstract

Transient myeloproliferative disease (TMD) is often associated with a trisomy 21 cell line, but it is not always associated with clinical signs of Down syndrome. We report on a phenotypically normal newborn boy who presented with a high white blood cell count, undifferentiated blasts, and cutaneous leukemic infiltrates and compare this patient with the literature on TMD and trisomy 21. Chromosome analysis of bone marrow, and subsequently of skin fibroblasts, documented constitutional mosaicism for trisomy 21. A decrease in the frequency of blast cells paralleled a decrease in cells demonstrating trisomy 21 in hematopoietic tissues, and a complete clinical recovery was seen without the use of chemotherapy. Recognition of this transient form of congenital leukemia is important to prevent the unnecessary use of toxic chemotherapeutic agents in such patients.

Entities:  

Mesh:

Year:  1995        PMID: 8533839     DOI: 10.1002/ajmg.1320580404

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

1.  Trisomy 21 associated transient neonatal myeloproliferation in the absence of Down's syndrome.

Authors:  M Richards; J Welch; A Watmore; D Readett; A J Vora
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

2.  The phenotype of persons having mosaicism for trisomy 21/Down syndrome reflects the percentage of trisomic cells present in different tissues.

Authors:  Paulie Papavassiliou; Timothy P York; Nurcan Gursoy; Gloria Hill; Lauren Vanner Nicely; Usha Sundaram; Allison McClain; Steven H Aggen; Lindon Eaves; Brien Riley; Colleen Jackson-Cook
Journal:  Am J Med Genet A       Date:  2009-02-15       Impact factor: 2.802

3.  Down syndrome with different hematological manifestations: a short series of 3 cases with review of literature.

Authors:  Prabhu Manivannan; Priavadhana Rajan Prasaad; Rakhee Kar; Debdatta Basu
Journal:  Indian J Hematol Blood Transfus       Date:  2012-02-01       Impact factor: 0.900

4.  Transient myeloproliferative disorder as the presenting feature for mosaic trisomy 21.

Authors:  Nicole Baca; Pedro A Sanchez-Lara; Rhona Schreck; Celeste C Eno; Fataneh Majlessipour
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.